博莱霉素
胸腺肽
肺
纤维化
体内
肺纤维化
背景(考古学)
肺纤维化
医学
促炎细胞因子
免疫学
炎症
生物
病理
内科学
古生物学
化疗
生物技术
作者
Enrico Conte,Tiziana Genovese,Elisa Gili,Emanuela Esposito,Maria Iemmolo,Mary Fruciano,Evelina Fagone,Maria Provvidenza Pistorio,Nunzio Crimi,Salvatore Cuzzocrea,Carlo Vancheri
标识
DOI:10.1111/j.1749-6632.2012.06694.x
摘要
Thymosin β4 (Tβ4) has been found to have several biological activities related to antiscarring and reduced fibrosis. For example, the anti‐inflammatory properties of Tβ4 and its splice variant have been shown in the eye and skin. Moreover, Tβ4 treatment prevents profibrotic gene expression in cardiac and in hepatic cells in vitro and in vivo . In a recent study on scleroderma patients it was hypothesized that Tβ4 may exert a protective effect during human lung injury. In an ongoing study, we have explored the putative Tβ4 protective role in the lung context by utilizing a well‐known in vivo model. We have observed significant protective effects of Tβ4 on bleomycin‐induced lung damage, the main outcomes being the halting of the inflammatory process and a substantial reduction of histological evidence of lung injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI